Literature DB >> 2769017

Effect of solubility on the gastrointestinal absorption of aluminum from various aluminum compounds in the rat.

D H Froment1, B Buddington, N L Miller, A C Alfrey.   

Abstract

The present study was carried out to determine whether the insoluble property of most aluminum compounds was the reason for the limited absorption of this element from the gastrointestinal tract. Aluminum compounds of varying degrees of solubility were studied. At pH 3, more than 25% of the aluminum from all of the compounds studied (with the exception of sucralfate [13%]) was in solution. At pH 6, the solubility of aluminum in Al(OH)3 and sucralfate was less than 1%; it was 15% in AlCl3 and 33% in aluminum lactate. Aluminum solubility did not change with a change in pH for the citrate compounds, which varied between 38%, with sucralfate plus citric acid, and 91%, with aluminum citrate. The fraction of the administered dose of aluminum absorbed as estimated by urinary excretion after gastric gavage was 0.015% for sucralfate and Al(OH)3, 0.037% for AlCl3 and aluminum lactate, and greater than 0.80% for all aluminum compounds administered with citrate. A similar relationship was found between the solubility of the aluminum compounds and absorption, as determined by calculated absorption from the changes in plasma aluminum levels. Solubility alone, however, could not totally explain the effect of citrate on aluminum absorption. The solubility of aluminum in aluminum lactate and sucralfate plus citric acid were the same at pH 6. Absorption of aluminum from aluminum lactate, however, was only 1.6% as much as that found for sucralfate plus citric acid.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2769017

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  9 in total

Review 1.  Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients?

Authors:  Francesco Locatelli; Lucia Del Vecchio
Journal:  J Nephrol       Date:  2017-07-17       Impact factor: 3.902

Review 2.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

Review 3.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

4.  Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies.

Authors:  Sabrina Falkowski; Patrick Trouillas; Jean-Luc Duroux; Jean-Marie Bonnetblanc; Pierre Clavère
Journal:  Support Care Cancer       Date:  2009-12-09       Impact factor: 3.603

5.  Aluminum accumulation in serum, liver and spleen of Fe-depleted and Fe-adequate rats.

Authors:  T S Brown; R Schwartz
Journal:  Biol Trace Elem Res       Date:  1992-07       Impact factor: 3.738

6.  Single-dose toxicokinetics of aluminum in the rat.

Authors:  M Wilhelm; X J Zhang; D Hafner; F K Ohnesorge
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

Review 7.  Safety of new phosphate binders for chronic renal failure.

Authors:  Mahmoud Loghman-Adham
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?

Authors:  David W Mudge; David W Johnson; Carmel M Hawley; Scott B Campbell; Nicole M Isbel; Carolyn L van Eps; James J B Petrie
Journal:  BMC Nephrol       Date:  2011-05-13       Impact factor: 2.388

9.  Ferric citrate hydrate as a phosphate binder and risk of aluminum toxicity.

Authors:  Ajay Gupta
Journal:  Pharmaceuticals (Basel)       Date:  2014-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.